Current strategies to reduce the risk of transmissible, transfusion-associated infections rely
on donor deferral and testing procedures, filtration or gamma irradiation of blood products to …

From blood donor collection to transfusion of the recipient, there are several layers of
protection of the blood supply. These measures combined with huge progresses over the …

The current multi-layered interventional approaches to blood safety have dramatically
reduced the risk of viral contamination of blood components. Nowadays most of the residual …

Transfusion-transmitted infections caused by viruses, bacteria, and protozoa have been
extensively reported for the past three decades. In the early 1980s, the HIV epidemic …

Agents that are transmissible by blood or its derivatives typically have long incubation
periods, may often be asymptomatic for several years and can set up carrier or latent …

Bacterial contamination remains a leading factor for transfusion-associated serious
morbidity and mortality. Pathogen reduction procedures offer a pro-active approach to …

For more than 50 years there has been an ongoing effort to combat transfusion‐transmitted
infections and provide patients with the safest possible blood. This initiative has driven much …

Pathogen‐reduction (inactivation) provides a proactive approach to reducing transfusion‐
transmitted infection. Pathogen‐reduction technologies have been successfully …

Although the risks of transfusion‐transmitted infection are currently very small compared with
other medical interventions, the perception remains that these risks are significant. Infection …

Background and Objectives The residual risk for transfusion‐transmitted viral infections has
been reduced to less than 1: 1 000 000 via improvements in various techniques (eg donor …